The market expects Inspire Medical Systems (INSP) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter. We know ...

Learn more about whether Inspire Medical Systems, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

Inspire Medical Systems, Inc. INSP announced preliminary revenues for the fourth quarter and full year 2024 yesterday. Despite the robust preliminary results, the company’s shares plunged nearly ...

To fuel our continued growth and advance the adoption of Inspire therapy, the Company implemented the following organizational changes: Finally, Dr. Charisse Sparks, Chief Medical Officer ...

Nisa Investment Advisors LLC lifted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 37.3% during the fourth quarter, Holdings Channel reports. The firm owned 368 ...

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA ...